三達膜(688101.SH):取消實施募投項目“無機陶瓷納濾芯及其淨水器生產線項目”
格隆匯9月30日丨三達膜(688101.SH)公佈,因募投項目“無機陶瓷納濾芯及其淨水器生產線項目”的建設用地無法如期取得,公司於2021年9月30日召開第三屆董事會第二十六次會議、第三屆監事會第十八次會議,會議審議通過了《關於取消實施部分募投項目的議案》,同意公司取消實施募投項目“無機陶瓷納濾芯及其淨水器生產線項目”。該事項尚需提交公司股東大會進行審議,因取消實施募投項目存在的風險具有不確定性,敬請廣大投資者知悉風險,謹慎決策。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.